C84.90
Mature T/NK-cell lymphomas, unspecified, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
C84.90 refers to a type of lymphoma known as mature T-cell or natural killer (NK)-cell lymphoma that has not been specifically classified by its location in the body. These are rare forms of blood cancers that originate from T lymphocytes or NK cells, which are essential components of the immune system. Because the exact site of the lymphoma is not specified, this code encompasses various locations where these cancers may develop, making diagnosis and treatment planning more complex.
Causes & Symptoms
Clinical Causes: Genetic mutations: Abnormalities in genes that control cell growth and division may contribute. Viral infections: Certain viruses, such as Epstein-Barr virus (EBV), have been associated with these lymphomas. Immune system dysfunction: Conditions that weaken or overactivate the immune system can increase risk. Environmental exposures: Prolonged contact with certain chemicals or toxins may play a role. Age and gender: Usually occurs in adults, with some variations based on demographics.
Key Symptoms: Swollen lymph nodes: Usually painless lumps in the neck, armpits, or groin. Unintentional weight loss: Significant weight loss without trying. Fever: Persistent or recurring fever unrelated to infections. Night sweats: Drenching sweats during sleep. Fatigue: A general feeling of tiredness and lack of energy. Abdominal pain or swelling: When the lymphoma affects abdominal organs. Skin changes: Such as rashes or nodules if the skin is involved. Breathing difficulties: If the lymphoma involves chest organs.
Diagnostic & Treatment
Diagnosis Path: The diagnosis of mature T/NK-cell lymphomas relies on a combination of methods. Initially, a doctor will perform a physical exam and review medical history, paying close attention to lymphatic system symptoms. Imaging tests like CT scans, PET scans, or MRI might be used to identify affected areas. A definitive diagnosis requires a biopsy, where a sample of affected tissue is examined microscopically to confirm the presence of malignant T or NK cells. Additional laboratory tests may include immunophenotyping, flow cytometry, and genetic studies to determine the specific subtype and characteristics of the lymphoma.
Treatment Protocols: Chemotherapy: The main treatment, often involving combination drug regimens aimed at destroying cancer cells. Radiation therapy: Used to target specific areas of involvement, especially in localized disease. Targeted therapy: Medications designed to interfere with specific molecules involved in the growth of lymphoma cells. Immunotherapy: Treatments that help boost the immune system to fight cancer, such as monoclonal antibodies. Stem cell transplant: Sometimes considered for advanced cases to replace diseased bone marrow with healthy cells. Clinical trials: Participation in research studies exploring new treatments may be an option.
Clinical Advice & FAQs
Billing Guidance
Is C84.90 a billable ICD-10 code?
Yes, C84.90 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.90?
Clinical documentation must specify the nature of Mature T/NK-cell lymphomas, unspecified, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference